Market revenue in 2023 | USD 25.0 million |
Market revenue in 2030 | USD 47.1 million |
Growth rate | 9.5% (CAGR from 2023 to 2030) |
Largest segment | Human donor tissue-derived products |
Fastest growing segment | Human Donor Tissue-Derived Products |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Human Donor Tissue-Derived Products, Acellular Animal-derived Products |
Key market players worldwide | 3M Co, Organogenesis Holdings Inc Class A, Integra Lifesciences Holdings Corp, Smith & Nephew PLC, MiMedx Group Inc, Essity AB Class B, Stryker Corp, Vericel Corp, Mallinckrodt PLC Ordinary Shares - New, Tissue Regenix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biological skin substitutes market will help companies and investors design strategic landscapes.
Human donor tissue-derived products was the largest segment with a revenue share of 66.8% in 2023. Horizon Databook has segmented the Japan biological skin substitutes market based on human donor tissue-derived products, acellular animal-derived products covering the revenue growth of each sub-segment from 2018 to 2030.
Some of the key factors contributing to the growth of medical device outsourcing market in Japan are technological advancements and considerable healthcare expenditure. Moreover, the Japanese government is actively investing in the improvement of healthcare services in the country.
The region is expected to dominate the Asia Pacific medical device outsourcing market during the forecast period, owing to a rise in demand for new and cost-effective medical devices. The presence of a stringent regulatory framework and standards for medical device manufacturing is leading to an increase in overall costs.
Thus, an increase in the need to maintain the standards and curb healthcare expenditure simultaneously is anticipated to drive the market in this region. Furthermore, high dependence of industry players on economic conditions, which are fluctuating in this region, is expected to propel the demand for consulting services.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan biological skin substitutes market , including forecasts for subscribers. This country databook contains high-level insights into Japan biological skin substitutes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account